Seres Therapeutics (1S90.F) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.62
-1.31
1
3.32

Details

Expected EPS
0.39724548996
Actual EPS
0.8176872
Surprise EPS
0.42
Surprise Percent
+105.84%

Description

Seres Therapeutics (1S90.F) has reported earnings of 0.8176872 per share for Q4 2025.

0 Comments

Share your thoughts